Role of cancer-associated fibroblasts in breast cancer development and prognosis

International Journal of Developmental Biology

Volumn 55, Issue 7-9, 2011, Pages 841-849

  Aboussekhra, Abdelilah ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Breast cancer; Cancer associated fibroblasts; Paracrine signaling; Prognosis

Indexed keywords

CAVEOLIN 1; CYCLIN DEPENDENT KINASE 1; MATRIX METALLOPROTEINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CELL TYPE; CYTOLOGY; FIBROBLAST; HUMAN; METASTASIS POTENTIAL; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STROMA; TUMOR CELL; TUMOR MICROENVIRONMENT;

BREAST NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; FIBROBLASTS; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; PROGNOSIS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 82555196948     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.113362aa     Document Type: Review

References (107)

1. AI, L., KIM, W.J., KIM, T.Y., FIELDS, C.R., MASSOLL, N.A., ROBERTSON, K.D., and BROWN, K.D. (2006). Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res 66: 7899-7909.
2. ALLINEN, M., BEROUKHIM, R., CAI, L., BRENNAN, C., LAHTI-DOMENICI, J., HUANG, H., PORTER, D., HU, M., CHIN, L., RICHARDSON, A., et al., (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
3. ARENDT, L.M., RUDNICK, J.A., KELLER, P.J., and KUPERWASSER, C. (2009). Stroma in breast development and disease. Semin Cell Dev Biol 21: 11-18.
4. AZZARONE, B., MAREEL, M., BILLARD, C., SCEMAMA, P., CHAPONNIER, C., and MACIEIRA-COELHO, A. (1984). Abnormal properties of skin fibroblasts from patients with breast cancer. Int J Cancer 33: 759-764.
5. BACHELDER, R.E., WENDT, M.A., and MERCURIO, A.M. (2002). Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206.
6. BAR, J., MOSKOVITS, N., and OREN, M. (2009). Involvement of stromal p53 in tumor-stroma interactions. Semin Cell Dev Biol 21: 47-54.
7. BARTH, P.J., EBRAHIMSADE, S., RAMASWAMY, A., and MOLL, R. (2002). CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 440: 298-303.
8. BASSET, P., BELLOCQ, J.P., WOLF, C., STOLL, I., HUTIN, P., LIMACHER, J.M., PODHAJCER, O.L., CHENARD, M.P., RIO, M.C., and CHAMBON, P. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704.
9. BAUER, M., SU, G., CASPER, C., HE, R., REHRAUER, W., and FRIEDL, A. (2010). Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 29: 1732-1740.
10. BEACHAM, D.A., and CUKIERMAN, E. (2005). Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 15: 329-341.
11. BERNFIELD, M., GOTTE, M., PARK, P.W., REIZES, O., FITZGERALD, M.L., LINCECUM, J., and ZAKO, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
12. BHOWMICK, N.A., NEILSON, E.G., and MOSES, H.L. (2004). Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337.
13. BOURAS, T., LISANTI, M.P., and PESTELL, R.G. (2004). Caveolin-1 in breast cancer. Cancer Biol Ther 3: 931-941.
14. CAMPBELL, I., POLYAK, K., and HAVIV, I. (2009). Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution. Cancer Res 69: 6765-6768; discussion 6769.
15. CAMPBELL, I., QIU, W., and HAVIV, I. (2011). Genetic changes in tumour microenvironments. J Pathol 223: 450-458.
16. CAMPS, J.L., CHANG, S.M., HSU, T.C., FREEMAN, M.R., HONG, S.J., ZHAU, H.E., VON ESCHENBACH, A.C., and CHUNG, L.W. (1990). Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 87: 75-79.
17. CARDONE, A., TOLINO, A., ZARCONE, R., BORRUTO CARACCIOLO, G., and TARTAGLIA, E. (1997). Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med 39: 174-177.
18. CASEY, T., BOND, J., TIGHE, S., HUNTER, T., LINTAULT, L., PATEL, O., ENEMAN, J., CROCKER, A., WHITE, J., TESSITORE, J., et al., (2009). Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 114: 47-62.
19. CHENG, J.D., and WEINER, L.M. (2003). Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003. Clin Cancer Res 9: 1590-1595.
20. CHENG, N., BHOWMICK, N.A., CHYTIL, A., GORKSA, A.E., BROWN, K.A., MURAOKA, R., ARTEAGA, C.L., NEILSON, E.G., HAYWARD, S.W., and MOSES, H.L. (2005). Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-and HGF-mediated signaling networks. Oncogene 24: 5053-5068.
21. CULLY, M., YOU, H., LEVINE, A.J., and MAK, T.W. (2006). Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184-192.
22. DE KRUIJF, E.M., VAN NES, J.G., VAN DE VELDE, C.J., PUTTER, H., SMIT, V.T., LIEFERS, G.J., KUPPEN, P.J., TOLLENAAR, R.A., and MESKER, W.E. (2011). Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 125: 687-696.
23. DE WEVER, O., DEMETTER, P., MAREEL, M., and BRACKE, M. (2008). Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238.
24. DVORAK, H.F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
25. EL-HAIBI, C.P., and KARNOUB, A.E. (2010). Mesenchymal stem cells in the pathogenesis and therapy of breast cancer. J Mammary Gland Biol Neoplasia 15: 399-409.
26. ENG, C., LEONE, G., ORLOFF, M.S., and OSTROWSKI, M.C. (2009). Genomic alterations in tumor stroma. Cancer Res 69: 6759-6764.
27. ENGELMAN, J.A., LEE, R.J., KARNEZIS, A., BEARSS, D.J., WEBSTER, M., SIEGEL, P., MULLER, W.J., WINDLE, J.J., PESTELL, R.G., and LISANTI, M.P. (1998). Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem 273: 20448-20455.
28. FARMER, P., BONNEFOI, H., ANDERLE, P., CAMERON, D., WIRAPATI, P., BECETTE, V., ANDRE, S., PICCART, M., CAMPONE, M., BRAIN, E., et al., (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15: 68-74.
29. FIEGL, H., MILLINGER, S., GOEBEL, G., MULLER-HOLZNER, E., MARTH, C., LAIRD, P.W., and WIDSCHWENDTER, M. (2006). Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res 66: 29-33.
30. FINAK, G., BERTOS, N., PEPIN, F., SADEKOVA, S., SOULEIMANOVA, M., ZHAO, H., CHEN, H., OMEROGLU, G., METERISSIAN, S., OMEROGLU, A., et al., (2008). Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527.
31. FRIEDL, A. (2009). Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions. Semin Cell Dev Biol 21: 66-71.
32. FUKINO, K., SHEN, L., PATOCS, A., MUTTER, G.L., and ENG, C. (2007). Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 297: 2103-2111.
33. GABBIANI, G., RYAN, G.B., and MAJNE, G. (1971). Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27: 549-550.
34. HAGGIE, J.A., SELLWOOD, R.A., HOWELL, A., BIRCH, J.M., and SCHOR, S.L. (1987). Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro. Lancet 1: 1455-1457.
35. HANNAN, M.A., SIDDIQUI, Y., ROSTOM, A., AL-AHDAL, M.N., CHAUDHARY, M.A., and KUNHI, M. (2001). Evidence of DNA repair/processing defects in cultured skin fibroblasts from breast cancer patients. Cancer Res 61: 3627-3631.
36. HASEBE, T., TAMURA, N., OKADA, N., HOJO, T., AKASHI-TANAKA, S., SHIMIZU, C., TSUDA, H., SHIBATA, T., SASAJIMA, Y., IWASAKI, M., et al., (2010). p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy. Hum Pathol 41: 262-270.
37. HAWSAWI, N.M., GHEBEH, H., HENDRAYANI, S.F., TULBAH, A., AL-EID, M., AL-TWEIGERI, T., AJARIM, D., ALAIYA, A., DERMIME, S., and ABOUSSEKHRA, A. (2008). Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 68: 2717-2725.
38. HU, M., PELUFFO, G., CHEN, H., GELMAN, R., SCHNITT, S., and POLYAK, K. (2009). Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci USA 106: 3372-3377.
39. HU, M., and POLYAK, K. (2008). Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 44: 2760-2765.
40. HU, M., YAO, J., CAI, L., BACHMAN, K.E., VAN DEN BRULE, F., VELCULESCU, V., and POLYAK, K. (2005). Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37: 899-905.
41. HUANG, M., LI, Y., ZHANG, H., and NAN, F. (2010). Breast cancer stromal fibroblasts promote the generation of CD44+CD24-cells through SDF-1/CXCR4 interaction. J. Exp. Clin. Cancer Res. 29: 80.
42. JEMAL, A., BRAY, F., CENTER, M.M., FERLAY, J., WARD, E., and FORMAN, D. (2011). Global cancer statistics. Ca Cancer J Clin 61: 69-90.
43. JEON, E.S., MOON, H.J., LEE, M.J., SONG, H.Y., KIM, Y.M., CHO, M., SUH, D.S., YOON, M.S., CHANG, C.L., JUNG, J.S., et al., (2008). Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 26: 789-797.
44. KALLURI, R., and WEINBERG, R.A. (2009). The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
45. KALLURI, R., and ZEISBERG, M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
46. KESSENBROCK, K., PLAKS, V., and WERB, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
47. KHWAJA, F.W., SVOBODA, P., REED, M., POHL, J., PYRZYNSKA, B., and VAN MEIR, E.G. (2006). Proteomic identification of the wt-p53-regulated tumor cell secretome. Oncogene 25: 7650-7661.
48. KIARIS, H., CHATZISTAMOU, I., TRIMIS, G., FRANGOU-PLEMMENOU, M., PAFITI-KONDI, A., and KALOFOUTIS, A. (2005). Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65: 1627-1630.
49. KIM, J.B., STEIN, R., and O'HARE, M.J. (2005). Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol 26: 173-185.
50. KOBAYASHI, T., TSUDA, H., MORIYA, T., YAMASAKI, T., KIKUCHI, R., UEDA, S., OMATA, J., YAMAMOTO, J., and MATSUBARA, O. (2009). Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis. Breast Cancer Res Treat 123: 733-745.
51. KOJIMA, Y., ACAR, A., EATON, E.N., MELLODY, K.T., SCHEEL, C., BEN-PORATH, I., ONDER, T.T., WANG, Z.C., RICHARDSON, A.L., WEINBERG, R.A., et al., (2010). Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci USA 107: 20009-20014.
52. KOMAROVA, E.A., DIATCHENKO, L., ROKHLIN, O.W., HILL, J.E., WANG, Z.J., KRIVOKRYSENKO, V.I., FEINSTEIN, E., and GUDKOV, A.V. (1998). Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17: 1089-1096.
53. KUPERWASSER, C., CHAVARRIA, T., WU, M., MAGRANE, G., GRAY, J.W., CAREY, L., RICHARDSON, A., and WEINBERG, R.A. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101: 4966-4971.
54. KUROSE, K., GILLEY, K., MATSUMOTO, S., WATSON, P.H., ZHOU, X.P., and ENG, C. (2002). Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32: 355-357.
55. LEE, S.W., REIMER, C.L., OH, P., CAMPBELL, D.B., and SCHNITZER, J.E. (1998). Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16: 1391-1397.
56. LIN, H.J., ZUO, T., CHAO, J.R., PENG, Z., ASAMOTO, L.K., YAMASHITA, S.S., and HUANG, T.H. (2009). Seed in soil, with an epigenetic view. Biochim Biophys Acta 1790: 920-924.
57. LIN, H.J., ZUO, T., LIN, C.H., KUO, C.T., LIYANARACHCHI, S., SUN, S., SHEN, R., DEATHERAGE, D.E., POTTER, D., ASAMOTO, L., et al., (2008). Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells. Cancer Res 68: 10257-10266.
58. LYNCH, C.C., and MATRISIAN, L.M. (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561-573.
59. MA, X.J., DAHIYA, S., RICHARDSON, E., ERLANDER, M., and SGROI, D.C. (2009). Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11: R7.
60. MAEDA, T., DESOUKY, J., and FRIEDL, A. (2006). Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene 25: 1408-1412.
61. MAKRETSOV, N.A., HAYES, M., CARTER, B.A., DABIRI, S., GILKS, C.B., and HUNTSMAN, D.G. (2007). Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol 20: 84-89.
62. MASSAGUE, J. (2008). TGFbeta in Cancer. Cell 134: 215-230.
63. MASSON, R., LEFEBVRE, O., NOEL, A., FAHIME, M.E., CHENARD, M.P., WENDLING, C., KEBERS, F., LEMEUR, M., DIERICH, A., FOIDART, J.M., et al., (1998). In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140: 1535-1541.
64. MATSUMOTO, K., and NAKAMURA, T. (2006). Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119: 477-483.
65. MISHRA, P.J., MISHRA, P.J., HUMENIUK, R., MEDINA, D.J., ALEXE, G., MESIROV, J.P., GANESAN, S., GLOD, J.W., and BANERJEE, D. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339.
66. MOINFAR, F., MAN, Y.G., ARNOULD, L., BRATTHAUER, G.L., RATSCHEK, M., and TAVASSOLI, F.A. (2000). Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60: 2562-2566.
67. MORI, L., BELLINI, A., STACEY, M.A., SCHMIDT, M., and MATTOLI, S. (2005). Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304: 81-90.
68. MOSKOVITS, N., KALINKOVICH, A., BAR, J., LAPIDOT, T., and OREN, M. (2006). p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 66: 10671-10676.
69. NABESHIMA, K., INOUE, T., SHIMAO, Y., and SAMESHIMA, T. (2002). Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52: 255-264.
70. NOEL, A., DE PAUW-GILLET, M.C., PURNELL, G., NUSGENS, B., LAPIERE, C.M., and FOIDART, J.M. (1993). Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br J Cancer 68: 909-915.
71. ORIMO, A., GUPTA, P.B., SGROI, D.C., ARENZANA-SEISDEDOS, F., DELAUNAY, T., NAEEM, R., CAREY, V.J., RICHARDSON, A.L., and WEINBERG, R.A. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
72. PAULSSON, J., SJOBLOM, T., MICKE, P., PONTEN, F., LANDBERG, G., HELDIN, C.H., BERGH, J., BRENNAN, D.J., JIRSTROM, K., and OSTMAN, A. (2009). Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol 175: 334-341.
73. PIETRAS, K., and OSTMAN, A. (2010). Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316: 1324-1331.
74. PINTO, M.P., BADTKE, M.M., DUDEVOIR, M.L., HARRELL, J.C., JACOBSEN, B.M., and HORWITZ, K.B. (2010). Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. Cancer 70: 2655-2664.
75. POLYAK, K., and KALLURI, R. (2010). The Role of the Microenvironment in Mammary Gland Development and Cancer. Cold Spring Harb Perspect Biol 2010: 30.
76. POLYAK, K., and WEINBERG, R.A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
77. POTENTA, S., ZEISBERG, E., and KALLURI, R. (2008). The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99: 1375-1379.
78. RIVENBARK, A.G., LIVASY, C.A., BOYD, C.E., KEPPLER, D., and COLEMAN, W.B. (2007). Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. Exp Mol Pathol 83: 188-197.
79. RONNOV-JESSEN, L., PETERSEN, O.W., KOTELIANSKY, V.E., and BISSELL, M.J. (1995). The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95: 859-873.
80. ROZENCHAN, P.B., CARRARO, D.M., BRENTANI, H., DE CARVALHO MOTA, L.D., BASTOS, E.P., EFERREIRA, E.N., TORRES, C.H., KATAYAMA, M.L., ROELA, R.A., LYRA, E.C., et al., (2009). Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer 125: 2767-2777.
81. SADLONOVA, A., BOWE, D.B., NOVAK, Z., MUKHERJEE, S., DUNCAN, V.E., PAGE, G.P., and FROST, A.R. (2009). Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts. Cancer Microenviron 2: 9-21.
82. SAPPINO, A.P., SCHURCH, W., and GABBIANI, G. (1990). Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63: 144-161.
83. SAPPINO, A.P., SKALLI, O., JACKSON, B., SCHURCH, W., and GABBIANI, G. (1988). Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 41: 707-712.
84. SCHOR, S.L., and SCHOR, A.M. (2001). Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 3: 373-379.
85. SCHOR, S.L., SCHOR, A.M., DURNING, P., and RUSHTON, G. (1985). Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels. J Cell Sci 73: 235-244.
86. SHEKHAR, M.P., WERDELL, J., SANTNER, S.J., PAULEY, R.J., and TAIT, L. (2001). Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 61: 1320-1326.
87. SLOAN, E.K., CIOCCA, D.R., POULIOT, N., NATOLI, A., RESTALL, C., HENDERSON, M.A., FANELLI, M.A., CUELLO-CARRION, F.D., GAGO, F.E., and ANDERSON, R.L. (2009). Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 174: 2035-2043.
88. SOTGIA, F., DEL GALDO, F., CASIMIRO, M.C., BONUCCELLI, G., MERCIER, I., WHITAKER-MENEZES, D., DAUMER, K.M., ZHOU, J., WANG, C., KATIYAR, S., et al., (2009). Caveolin-1-/-null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am J Pathol 174: 746-761.
89. SPAETH, E.L., DEMBINSKI, J.L., SASSER, A.K., WATSON, K., KLOPP, A., HALL, B., ANDREEFF, M., and MARINI, F. (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992.
90. STUELTEN, C.H., DACOSTA BYFIELD, S., ARANY, P.R., KARPOVA, T.S., STETLER-STEVENSON, W.G., and ROBERTS, A.B. (2005). Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci 118: 2143-2153.
91. SU, G., BLAINE, S.A., QIAO, D., and FRIEDL, A. (2007). Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J Biol Chem 282: 14906-14915.
92. TARIN, D. (1969). Fine structure of murine mammary tumours: the relationship between epithelium and connective tissue in neoplasms induced by various agents. Br J Cancer 23: 417-425.
93. TEICHER, B.A., and FRICKER, S.P. (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931.
94. TOMASEK, J.J., GABBIANI, G., HINZ, B., CHAPONNIER, C., and BROWN, R.A. (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363.
95. TRIMBOLI, A.J., CANTEMIR-STONE, C.Z., LI, F., WALLACE, J.A., MERCHANT, A., CREASAP, N., THOMPSON, J.C., CASERTA, E., WANG, H., CHONG, J.L., et al., (2009). Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: 1084-1091.
96. TRIMIS, G., CHATZISTAMOU, I., POLITI, K., KIARIS, H., and PAPAVASSILIOU, A.G. (2008). Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Hum Mol Genet 17: 3596-3600.
97. TRIMMER, C., SOTGIA, F., WHITAKER-MENEZES, D., BALLIET, R.M., EATON, G., MARTINEZ-OUTSCHOORN, U.E., PAVLIDES, S., HOWELL, A., IOZZO, R.V., PESTELL, R.G., et al., (2011). Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer 11: 383-394.
98. TYAN, S.W., KUO, W.H., HUANG, C.K., PAN, C.C., SHEW, J.Y., CHANG, K.J., LEE, E.Y., and LEE, W.H. (2011). Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. PLoS one 6: e15313.
99. VAUGHAN, M.B., HOWARD, E.W., and TOMASEK, J.J. (2000). Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257: 180-189.
100. WANG, T.N., ALBO, D., and TUSZYNSKI, G.P. (2002). Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery 132: 220-225.
101. WEBER, F., SHEN, L., FUKINO, K., PATOCS, A., MUTTER, G.L., CALDES, T., and ENG, C. (2006). Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 78: 961-972.
102. WERNERT, N., LOCHERBACH, C., WELLMANN, A., BEHRENS, P., and HUGEL, A. (2001). Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 21: 2259-2264.
103. WILLIAMS, T.M., LEE, H., CHEUNG, M.W., COHEN, A.W., RAZANI, B., IYENGAR, P., SCHERER, P.E., PESTELL, R.G., and LISANTI, M.P. (2004). Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia. J Biol Chem 279: 24745-24756.
104. WITKIEWICZ, A.K., CASIMIRO, M.C., DASGUPTA, A., MERCIER, I., WANG, C., BONUCCELLI, G., JASMIN, J.F., FRANK, P.G., PESTELL, R.G., KLEER, C.G., et al., (2009). Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle 8: 1654-1658.
105. WU, M., JUNG, L., COOPER, A.B., FLEET, C., CHEN, L., BREAULT, L., CLARK, K., CAI, Z., VINCENT, S., BOTTEGA, S., et al., (2009). Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice. Proc Natl Acad Sci USA 106: 7022-7027.
106. YAMASHITA, M., OGAWA, T., ZHANG, X., HANAMURA, N., KASHIKURA, Y., TAKAMURA, M., YONEDA, M., and SHIRAISHI, T. (2010). Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome. Breast Cancer 2010: 27.
107. ZEISBERG, E.M., POTENTA, S., XIE, L., ZEISBERG, M., and KALLURI, R. (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67: 10123-10128.